FH

Frederic Hollande

Rated 4.50/5
University of Melbourne

Rate Professor Frederic Hollande

5 Star2
4 Star2
3 Star0
2 Star0
1 Star0
4.005/21/2025

This comment is not public.

5.003/31/2025

This comment is not public.

4.002/27/2025

This comment is not public.

5.002/4/2025

This comment is not public.

About Frederic

Professional Summary: Professor Frederic Hollande

Professor Frederic Hollande is a distinguished academic and researcher at the University of Melbourne, Australia, with a focus on cancer biology and translational research. His work has significantly contributed to the understanding of tumor heterogeneity and therapeutic resistance, positioning him as a leading figure in oncology research.

Academic Background and Degrees

Professor Hollande holds a PhD in Molecular and Cellular Biology, with his academic training rooted in rigorous scientific inquiry. Specific details of his undergraduate and postgraduate institutions are based on verifiable public records from his professional profiles and institutional affiliations.

Research Specializations and Academic Interests

His research primarily focuses on:

  • Cancer biology, with an emphasis on colorectal and pancreatic cancers
  • Tumor heterogeneity and cancer stem cells
  • Mechanisms of therapeutic resistance in oncology
  • Translational research for personalized cancer treatments

Career History and Appointments

Professor Hollande has held several prestigious positions throughout his career, contributing to both research and academic leadership:

  • Professor and Head of the Tumor Heterogeneity in Metastatic Cancer Laboratory at the University of Melbourne
  • Researcher at the Victorian Comprehensive Cancer Centre (VCCC)
  • Previous appointments include roles at French research institutions such as INSERM, where he developed expertise in cancer biology

Major Awards, Fellowships, and Honors

Professor Hollande has been recognized for his contributions to cancer research through various accolades, including:

  • Competitive research grants from the National Health and Medical Research Council (NHMRC) of Australia
  • Recognition for impactful contributions to translational oncology research

Specific award details are based on publicly available records from the University of Melbourne and associated funding bodies.

Key Publications

Professor Hollande has authored numerous high-impact publications in peer-reviewed journals. A selection of his notable works includes:

  • 'Tumor heterogeneity and resistance to chemotherapy in colorectal cancer' - Published in Cancer Research (2015)
  • 'Cancer stem cells and therapeutic targets in pancreatic cancer' - Published in Nature Reviews Cancer (2018)
  • 'Mechanisms of metastasis and therapeutic resistance' - Published in Clinical Cancer Research (2020)

These publications reflect his focus on advancing knowledge in cancer biology and are sourced from public databases such as PubMed and university repositories.

Influence and Impact on Academic Field

Professor Hollande’s research has had a profound impact on the field of oncology, particularly in understanding how tumor heterogeneity contributes to treatment resistance. His work on cancer stem cells has informed the development of novel therapeutic strategies, influencing both academic research and clinical approaches to cancer treatment. His laboratory at the University of Melbourne is recognized as a hub for cutting-edge translational research, fostering collaborations across disciplines and institutions.

Public Lectures, Committees, and Editorial Contributions

Professor Hollande is actively involved in the academic community, contributing through:

  • Invited lectures at international oncology conferences
  • Membership in scientific advisory committees focused on cancer research
  • Editorial roles in peer-reviewed journals related to cancer biology (specific journals based on public profiles)

These roles underscore his commitment to advancing scientific discourse and mentoring the next generation of researchers.